U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H23N3O2S
Molecular Weight 393.502
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CJ-13610

SMILES

CC1=NC=CN1C2=CC=C(SC3=CC=CC(=C3)C4(CCOCC4)C(N)=O)C=C2

InChI

InChIKey=VPTONMHDLLMOOV-UHFFFAOYSA-N
InChI=1S/C22H23N3O2S/c1-16-24-11-12-25(16)18-5-7-19(8-6-18)28-20-4-2-3-17(15-20)22(21(23)26)9-13-27-14-10-22/h2-8,11-12,15H,9-10,13-14H2,1H3,(H2,23,26)

HIDE SMILES / InChI

Molecular Formula C22H23N3O2S
Molecular Weight 393.502
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 07:54:18 UTC 2023
Edited
by admin
on Sat Dec 16 07:54:18 UTC 2023
Record UNII
5275PJ1C59
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CJ-13610
Code English
2H-PYRAN-4-CARBOXAMIDE, TETRAHYDRO-4-(3-((4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENYL)THIO)PHENYL)-
Systematic Name English
4-(3-((4-(2-METHYL-1H-IMIDAZOL-1-YL)PHENYL)SULFANYL)PHENYL)TETRAHYDRO-2H-PYRAN-4-CARBOXAMIDE
Systematic Name English
Code System Code Type Description
FDA UNII
5275PJ1C59
Created by admin on Sat Dec 16 07:54:18 UTC 2023 , Edited by admin on Sat Dec 16 07:54:18 UTC 2023
PRIMARY
PUBCHEM
9821945
Created by admin on Sat Dec 16 07:54:18 UTC 2023 , Edited by admin on Sat Dec 16 07:54:18 UTC 2023
PRIMARY
CAS
179420-17-8
Created by admin on Sat Dec 16 07:54:18 UTC 2023 , Edited by admin on Sat Dec 16 07:54:18 UTC 2023
PRIMARY
EPA CompTox
DTXSID7047273
Created by admin on Sat Dec 16 07:54:18 UTC 2023 , Edited by admin on Sat Dec 16 07:54:18 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
REVERSIBLE
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
METABOLIC ENZYME -> SUBSTRATE
Related Record Type Details
METABOLITE -> PARENT
IN VITRO
METABOLITE -> PARENT
INN VITRO
METABOLITE -> PARENT
IN VITRO
METABOLITE -> PARENT
IN VITRO
METABOLITE -> PARENT
IN VITRO
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC IN HEALTHY FASTED MALE SUBJECTS

ORAL ADMINISTRATION

SINGLE DOSE

Tmax PHARMACOKINETIC IN HEALTHY FASTED MALE SUBJECTS

ORAL ADMINISTRATION

SINGLE DOSE

Biological Half-life PHARMACOKINETIC SINGLE DOSE

ORAL ADMINISTRATION

IN HEALTHY FASTED MALE SUBJECTS

Tmax PHARMACOKINETIC SINGLE DOSE

ORAL ADMINISTRATION

IN HEALTHY FASTED MALE SUBJECTS